Tesamorelin · Physician Directory

    Tesamorelin Prescribing Physicians

    Tesamorelin is an FDA-approved synthetic GHRH analog indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. It stimulates physiological growth hormone secretion and has demonstrated significant visceral adipose tissue reduction in clinical trials.

    0 results

    Sample profiles shown

    Be the first physician listed for Tesamorelin in your area.

    Claim your listing

    Tesamorelin · Clinical Reference

    Frequently Asked Questions

    Is Tesamorelin safe?

    Tesamorelin has been evaluated in FDA registration trials and post-marketing surveillance. Common side effects include injection-site reactions, joint pain, and peripheral edema.

    It should not be used in patients with active malignancy or during pregnancy. Your prescriber will screen for contraindications before initiating therapy.

    What does Tesamorelin do?

    Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce and release growth hormone in a physiological manner.

    It has been shown to significantly reduce visceral adipose tissue and improve body composition without the risks associated with exogenous growth hormone administration.

    How is Tesamorelin administered?

    Tesamorelin is administered via daily subcutaneous injection, typically in the abdomen. Treatment duration varies, but clinical trials have demonstrated sustained benefits with continued use.

    Dosing is standardized and should be managed by a prescriber experienced with growth hormone optimization.

    Is Tesamorelin FDA-approved?

    Yes. Tesamorelin is FDA-approved under the brand name Egrifta for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.

    It is also prescribed off-label by physicians for visceral fat reduction and growth hormone optimization in non-HIV patients.

    What conditions is Tesamorelin used for?

    The FDA-approved indication is HIV-associated lipodystrophy. Off-label uses include visceral fat reduction, cognitive support (emerging BDNF research), and age-related GH decline.

    It is increasingly used in functional medicine as an alternative to direct GH administration.

    How long does Tesamorelin take to work?

    Onset and magnitude of effect vary by patient. See the TruthTides evidence library for graded trial timelines and citations. Some patients report changes in body composition and energy within 4–8 weeks.

    Sustained use is generally required to maintain benefits.

    Can I get Tesamorelin without a prescription?

    No. Tesamorelin is a prescription medication. The branded product (Egrifta) requires a prescription, and compounded versions must also be prescribed by a licensed physician.

    How do I find a doctor who prescribes Tesamorelin?

    TruthTides maintains a directory of licensed prescribers experienced with clinically relevant peptides. Search by location, telehealth availability, and peptide expertise to find a qualified provider near you.

    Find a prescriber near you →